In summary, our investigations revealed that exogenously expressed ADAMTS16 missense mutations lead to cellular changes that enhance cisplatin sensitivity or inhibit cell growth and suppress tumor invasion and migration in platinum-resistant ovarian cancer. The gene discussed is ADAMTS16; the disease is ovarian carcinoma.